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Abstract Carboxypeptidase Y (CPY) inhibitor, IC, a yeast
cytoplasmic inhibitor in which the N-terminal amino acid is
acetylated, was expressed in Escherichia coli and produced as
an unacetylated form of IC (unaIC). Circular dichroism and
£uorescence measurements showed that unaIC and IC were
structurally identical and produce identical complexes with
CPY. However, the Ki values for unaIC for anilidase and pep-
tidase activity of CPY were much larger, by 700- and 60-fold,
respectively, than those of IC. The reactivities of phenylmethyl-
sulfonyl £uoride and p-chloromercuribenzoic acid toward the
CPY^unaIC complex were considerably higher than those to-
ward the CPY^IC complex. Thus, the N-terminal acetyl group
of IC is essential for achieving a tight interaction with CPY and
for its complete inactivation.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Carboxypeptidase Y (CPY) inhibitor, IC, a cytoplasmic in-
hibitor of vacuolar proteinases in the yeast Saccharomyces
cerevisiae, represents the only proteinous inhibitor that is spe-
ci¢c for a serine carboxypeptidase reported to date [1^3]. Re-
cently, IC was identi¢ed as a TFS1 gene product, which is
composed of 219 amino acid residues and is possibly involved
in nutrient-signaling pathways in starved yeast cells [3^5].
However, the relationship between the regulation of proteo-
lytic activity in vacuoles and the nutrient-signaling pathway
has not yet been elucidated.
IC is a competitive inhibitor of CPY, and forms a complex
with it [3,6]. The N-terminal amino acid is acetylated and
details of the involvement of the acetyl group in the inhibitory
function were recently reported, in which the inhibitor con-
stant, Ki, of the inhibitor, modi¢ed with an N-terminal His6
tag, was greatly increased [3,7].
In the present study, we report on the production of the
unacetylated form of IC (unaIC) using the Escherichia coli
expression system and an analysis of its structural and func-
tional properties to clarify the participation of the N-terminal
acetyl group in the inhibition of CPY.
2. Materials and methods
2.1. Materials
CPY was puri¢ed as previously described [8]. Synthetic oligonucleo-
tides were obtained from Japan Bio Services, Saitama, Japan. Restric-
tion endonucleases and DNA modi¢cation enzymes were obtained
from Toyobo, Tokyo, Japan. Butyl-Toyopearl 650S was purchased
from Tosoh, Tokyo, Japan. Superdex 75 and Superdex 200 were
from Pharmacia Fine Chemicals, Uppsala, Sweden. N-Benzoyl-L-ty-
rosine-p-nitroanilide (Bz-Tyr-pNA), phenylmethylsulfonyl £uoride
(PMSF), and p-chloromercuribenzoic acid (PCMB) were products of
Nacalai Tesque, Kyoto, Japan, in a purity of more than 99%. 0.1 M
sodium phosphate bu¡er, pH 7.0, containing 1 mM EDTA and 1 mM
dithiothreitol (DTT) used throughout the experiment is referred to as
bu¡er A.
2.2. Preparation of IC from S. cerevisiae
Strain BJ2168 of S. cerevisiae was used as the host for the expres-
sion of IC [9] and was transformed by the expression vector pYTF1,
which was constructed by insertion of the TFS1 gene into the KpnI
site of pYES2 (Invitrogen, San Diego, CA, USA). Cells grown in the
presence of 2% galactose for 42 h were harvested and disrupted by
freeze-thawing [3] in bu¡er A. Ammonium sulfate was added to the
homogenate to a concentration of 1.0 M. The solution was applied to
a butyl-Toyopearl column (30U60 mm) equilibrated with 1.0 M am-
monium sulfate in bu¡er A. IC, which eluted at 0.5 M ammonium
sulfate, was further puri¢ed by gel ¢ltration chromatographies succes-
sively using Superdex 200 and Superdex 75 columns (10U300 mm)
that had previously been equilibrated with bu¡er A containing 0.15 M
NaCl.
2.3. Preparation of unaIC from E. coli
E. coli BL21(DE3) was transformed by the expression vector
pETF1, produced by ligation of the TFS1 gene fragment into the
pET vector (Novagen, Madison, WI, USA). After the transformed
cells were grown in LB medium containing 50 Wg/ml ampicillin at
37‡C until the OD600 reached 0.6, protein expression was induced
by the addition of 1 mM isopropyl-1-thio-L-galactoside at 37‡C for
4 h. The collected cells were disrupted by ultrasonication in bu¡er A
containing 0.1 M NaCl. The precipitate collected by centrifugation of
the cell lysate was washed twice with 4% Triton X-100 in bu¡er A and
suspended in 50 mM Tris^HCl, pH 8.5, containing 6 M guanidine
hydrochloride, 10 mM DTT, and 1 mM EDTA, followed by incuba-
tion with shaking at 37‡C for 1 h. The soluble portion was dialyzed
overnight against bu¡er A containing 0.15 M NaCl. The puri¢ed
inhibitor was obtained by gel ¢ltration chromatography using a
Superdex 75 column (10U300 mm) equilibrated with the same bu¡er
as used in the dialysis.
2.4. Structural analysis
The N-terminal amino acid sequencing of unaIC was performed on
an Applied Biosystems model 476A protein sequencer, according to
the manufacturer’s instructions.
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The molecular masses of unaIC and IC were determined by matrix-
assisted laser desorption/ionization time of £ight (MALDI-TOF) mass
spectrometry using a Voyager RP mass spectrometer (Applied Bio-
systems, Foster City, CA, USA). Samples were prepared as follows.
The inhibitors, after desalting by reverse-phase chromatography, were
added to a matrix solution, 7 mg/ml 3,5-dimethoxy-4-hydroxycinnam-
ic acid in 33% acetonitrile (v/v) containing 0.2% tri£uoroacetic acid, to
give a ¢nal concentration of 3 WM. The system was calibrated with
standard proteins that included bovine serum albumin, bovine trypsi-
nogen, and horse apomyoglobin.
Circular dichroism (CD) spectra in the region 200^260 nm were
measured in a 0.1 cm sample cell with an optical path length at
25‡C with a Jasco J-720W spectropolarimeter. Protein concentrations
were adjusted to 8.2 WM in 10 mM sodium phosphate, pH 7.0, con-
taining 1 mM EDTA and 1 mM DTT. Baseline-corrected CD spectra
were deconvoluted with the CDFIT software program [10].
Intrinsic £uorescence was measured at 25‡C with a Shimadzu RF-
5300PC spectro£uorometer by exciting at 295 nm. The emission spec-
tra were recorded between 310 and 440 nm and quanti¢ed by specify-
ing the center of the spectral mass, GXf [11]. Protein concentrations in
50 mM sodium phosphate, pH 7.0, containing 1 mM EDTA, 1 mM
DTT, and 0.1 M NaCl were adjusted to 8.2 WM for inhibitors and 3.3
WM for proteinase^inhibitor complexes.
2.5. Determination of inhibitory constants
CPY (32.8 nM) was mixed with various concentrations of unaIC or
IC (0^656 nM) in 50 mM bis-Tris, pH 6.5, containing 1 mM EDTA,
10% N,N-dimethylformamide (v/v), and 0.3 mM Bz-Tyr-pNA or 1.0
mM benzyloxycarbonyl (CBZ)-Ala-Phe-OH. The initial hydrolytic
rates were determined at 25‡C as previously described [8,12]. The ap-
parent inhibitor constants, Ki(app), were derived from Henderson
plots [13]. The intrinsic inhibitor constants, Ki, were calculated assum-
ing competitive inhibition [6], using the following equation:
K i ¼ K iðappÞ=ð1þ ½S=KmÞ ð1Þ
where the Km values were taken as 0.57 mM and 5.5 mM for Bz-Tyr-
pNA and CBZ-Ala-Phe-OH, respectively.
2.6. Analysis of the inhibitor and CPY complex
Complex formation between unaIC or IC and CPY was analyzed by
gel ¢ltration with a Superdex 75 column (10U300 mm). The column
was calibrated with the following reference proteins: IgG, bovine
serum albumin, ovalbumin, carbonic anhydrase, and RNase A (Mr
160 000, 67 000, 43 000, 31 000, and 13 700, respectively). Mixtures
composed of CPY (11 WM) and unaIC or IC (0^22 WM) were applied
and eluted with bu¡er A containing 0.15 M NaCl at a £ow rate of 0.5
ml/min.
2.7. Reaction with PMSF and PCMB
Free CPY and complexes with unaIC and IC (2 WM) were incubated
with a 20-fold molar excess of PMSF or PCMB in 50 mM bis-Tris,
pH 6.5 at 25‡C for 30 min. Residual anilidase activities after the
reaction were determined in 0.1 M sodium phosphate solution, pH
7.0, containing 0.3 mM Bz-Tyr-pNA, 1 mM EDTA, 10% N,N-di-
methylformamide (v/v), and 1.2 M guanidine hydrochloride. Under
such conditions, PMSF and PCMB were extremely diluted and CPY^
inhibitor complexes exhibit an activity equivalent to that of free CPY
[3].
3. Results and discussion
3.1. Expression, puri¢cation, and chemical properties of unaIC
UnaIC was expressed as an inclusion body in E. coli strain
BL21(DE3) with the expression vector pETF1, which was
constructed in this study. In the ¢nal gel ¢ltration chromatog-
raphy, unaIC eluted as a single peak at the same position as
native IC. Approximately 45 mg of homogeneous unaIC was
obtained from 1 l of E. coli culture, as con¢rmed by SDS^
PAGE analysis.
Amino acid sequencing showed that the N-terminal amino
acid of unaIC was a methionine residue. MALDI-TOF mass
spectrometry indicated that the molecular mass of unaIC was
24 358.2 as predicted from its amino acid sequence, while the
molecular mass of native IC was larger by 42.3, which corre-
sponds to the mass of an acetyl group, 42.01 (Fig. 1A).
Mass spectrometric analyses of the tryptic fragments of
unaIC and IC revealed that masses of N-terminal peptides
(MNQAIDFAQASIDSYKK) were 1930.01 and 1971.96 for
unaIC and IC, respectively (data not shown). Thus, it can be
concluded that the recombinant protein puri¢ed herein (un-
aIC) was the unacetylated form of IC, the primary structure of
which was identical to that of native IC, except for the N-ter-
minal acetyl group.
Fig. 1. Structural properties of unaIC and its complex with CPY. A: MALDI-TOF mass spectra. A mixture of unaIC or IC (3 WM), 3,5-dimeth-
oxy-4-hydroxycinnamic acid (7 mg/ml), 33% acetonitrile, and 0.2% tri£uoroacetic acid was loaded on a sample plate and the calibration was
done using bovine serum albumin, bovine trypsinogen, and horse apomyoglobin. The spectra and molecular masses of unaIC and IC are shown
in the upper and lower half of the ¢gure, respectively. B: CD spectra. Protein concentrations of unaIC, IC, CPY^unaIC, and CPY^IC complexes
were 8.2 WM in 10 mM sodium phosphate, pH 7.0, containing 1 mM EDTA and 1 mM DTT. Open circles, unaIC ; closed circles, IC ; open tri-
angles, CPY^unaIC complex; closed triangles, CPY^IC complex. C: Fluorescence spectra. Intrinsic £uorescence was measured by exciting at
295 nm and the emission spectra were recorded between 310 and 440 nm. Protein concentrations of unaIC, IC, CPY^unaIC, and CPY^IC com-
plexes were 8.2, 8.2, 3.3, and 3.3 WM, respectively, in 50 mM sodium phosphate, pH 7.0, containing 1 mM EDTA, 1 mM DTT, and 0.1 M
NaCl. The symbols are the same as those in B.
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3.2. Comparison of structural and inhibitory properties of
IC and unaIC
The far-UV CD spectra of unaIC and IC were nearly iden-
tical (Fig. 1B): the K-helix, L-sheet, and random structure
contents of the inhibitors were calculated to be 0.8, 78, and
22% for the unacetylated form and 1.9, 80, and 18% for the
acetylated form, respectively, indicating that both inhibitors
are similar L-type proteins in which the L-structure is the
predominant structural element. The intrinsic £uorescence
spectra of unaIC and IC were nearly identical (Fig. 1C) and
the maximum wavelength, Vmax, and center of the spectral
mass, GXf, of both proteins were 342.5 nm and 28 340 cm31,
respectively. CD and £uorescence spectra indicate that unaIC
was correctly folded, forming the same gross structure as na-
tive IC.
The inhibitory e¡ects of unaIC and IC on anilidase activity
for Bz-Tyr-pNA and peptidase activity for CBZ-Ala-Phe-OH
of CPY were signi¢cantly di¡erent from each other (Fig. 2):
an equivalent molar concentration of unaIC inhibited only 7
and 13% of anilidase and peptidase activities for CPY, respec-
tively, and even a ¢ve-fold molar excess of unaIC inhibited the
activities by 30 and 35%, respectively, while an equivalent
molar concentration of IC inhibited 70^80% of both activities.
Based on these data, the intrinsic inhibitor constants, Ki, of
unaIC were calculated from Eq. 1 to be 400 nM and 330 nM
for Bz-Tyr-pNA and CBZ-Ala-Phe-OH hydrolysates, respec-
tively, while the Ki values of IC were 0.55 nM and 5.4 nM,
respectively. These results show that the inhibitory e⁄ciency
of unaIC was much smaller than that of IC, and the depen-
dence of unaIC on the substrate for CPY was largely di¡erent
from that of IC. The dependence of IC suggests that the bind-
ing a⁄nity of IC to the C-terminal binding site of CPY may
be di¡erent from it to the other subsites.
3.3. Complex formation of unaIC with CPY
Gel ¢ltration chromatography of the unaIC and CPY mix-
ture showed a peak corresponding to the unaIC and CPY
complex of Mr 89 000, which increased proportionally with
the addition of increasing amounts of unaIC (Fig. 3). When
equimolar mixtures of unaIC (Mr 25 000) and CPY (Mr
61 000) were applied to a column, a single peak having Mr
89 000 was obtained (chromatogram no. 4 in Fig. 3). These
elution pro¢les were the same with those for a mixture of IC
and CPY (data not shown), indicating that unaIC and IC form
a stable equimolecular complex of Mr 89 000 with CPY. Fur-
thermore, the far-UV CD and intrinsic £uorescence spectra of
the CPY^unaIC and CPY^IC complexes were nearly identical
(Fig. 1B,C), showing that the overall structure of the complex
was nearly unchanged as the result of N-terminal acetylation.
PMSF and PCMB, speci¢c reagents for the catalytic center
Ser146 and the S1 subsite residue Cys341 of CPY, respectively
[14^16], reacted more rapidly toward the CPY^unaIC complex
than toward the CPY^IC complex (Fig. 4), where the second
order reaction rates, k2nd, of PMSF and PCMB were 1.15 and
0.24 min31 mM31 toward the CPY^unaIC complex, respec-
Fig. 2. Stoichiometry of CPY inhibition by unaIC. CPY (32.8 nM)
was mixed with various amounts of unaIC or IC (0^656 nM) and
the residual activity of CPY was assayed using Bz-Tyr-pNA or
CBZ-Ala-Phe-OH as the substrate. Circles, unaIC ; triangles, IC ;
open symbols, Bz-Tyr-pNA activity; closed symbols, CBZ-Ala-Phe-
OH activity.
Fig. 3. Gel ¢ltration analysis of unaIC and CPY mixture. A mixture
of CPY and unaIC was applied to a Superdex 75 column (10U300
mm) and eluted with bu¡er A containing 0.15 M NaCl at a £ow
rate of 0.5 ml/min, by monitoring the absorbance at 280 nm. The
estimated molecular mass of each peak is shown in the ¢gure. Chro-
matogram no. 1, 11 WM unaIC ; no. 2, 11 WM CPY; no. 3, 5.5 WM
unaIC and 11 WM CPY mixture; no. 4, 11 WM unaIC and 11 WM
CPY mixture; no. 5, 22 WM unaIC and 11 WM CPY mixture.
Fig. 4. E¡ect of PMSF and PCMB on the CPY^unaIC complex.
CPY^unaIC, CPY^IC complexes, and CPY were allowed to react
with a 20-fold molar excess of PMSF or PCMB. Residual CPY ac-
tivity of the reaction mixture was assayed with respect to Bz-Tyr-
pNA in the presence of 1.2 M guanidine hydrochloride. The activity
before incubation was taken as 100%. Solid lines, CPY^unaIC com-
plex; dashed lines, CPY^IC complex; dotted lines, free CPY; open
circles, PMSF reaction; closed circles, PCMB reaction.
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tively, and 0.22 and 0.037 min31 mM31 toward the CPY^IC
complex, respectively, although these values were much small-
er than those found for free CPY (k2nd of PMSF and PCMB:
8.0 and 2.7 min31 mM31, respectively). These results indicate
that both IC and unaIC form a complex with CPY and mask
the catalytic Ser146 and Cys341 but these two residues were
more loosely covered in the CPY^unaIC complex than in the
CPY^IC complex, in terms of their ability to accept the very
strong inhibitors, PMSF and PCMB.
3.4. Participation of the N-terminal acetyl group of IC in the
inhibition of CPY
The present experiments using unaIC and its complex with
CPY demonstrates that the secondary and tertiary structures
of IC and the complex and its ability to form a complex were
negligibly a¡ected by the elimination of the N-terminal acetyl
group of IC. As shown in Fig. 2, however, the inhibitory
e⁄ciency of unaIC toward CPY was greatly decreased, com-
pared with that of IC : the Ki values of unaIC were increased
by about 700- and 60-fold, respectively, for anilidase and
peptidase activities. These results indicate that the interaction
of unaIC with CPY is weaker than that of IC at least in the
local region around the active site of CPY. In other words, the
N-terminal acetyl group is important for forming a tight com-
plex.
Considering that CBZ-Ala-Phe-OH contains the C-terminal
carboxyl group, the remarkable decrease in the Ki value of
unaIC with respect to CBZ-Ala-Phe-OH hydrolysis suggests
that the N-terminal K-amino group of unaIC disturbs the
binding of the carboxyl group to the C-terminal binding site
of CPY, in which a hydrogen bond network is formed [16^18].
Hence, the acetyl group of IC, when it is complexed with
CPY, would be situated adjacent to the substrate-binding sites
(S1 and S1P subsites and C-terminal binding site) and would
be involved in the masking of the active site of CPY. This
hypothesis is supported by the increased reactivity of PMSF
and PCMB with the CPY^unaIC complex.
The present study clearly demonstrates the functional in-
volvement of the N-terminal acetylation in IC and indicates
a novel mechanism of carboxypeptidase inhibition which dif-
fers from the stopper-like inhibition of carboxypeptidase A by
the C-terminal region of potato carboxypeptidase inhibitor
[19]. Although no de¢nitive information is available at present
regarding the nature of the binding of the acetyl group to
CPY, further studies on mutational analyses of the N-terminal
region and X-ray crystallography of CPY^IC complex would
clarify the speci¢c role of the N-terminal acetyl group in the
inhibition of IC.
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